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ABSTRACT
THE ROLE OF HISTIDINE IN THE MECHANISM OF 
IRON RELEASE FROM HUMAN SERUM TRANSFERRIN
by
Donna M. Martin 
University of New Hampshire, May, 1988
The role of non-coordinated histidines in the iron 
release mechanism of human serum transferrin has been 
investigated by chemical modification of the protein with 
ethoxyformic anhydride and aquopentaamine ruthenium(II), 
reagents specfic for histidines under mild conditions. 
Kinetic studies of the iron release reaction at pH 5 under 
the action of different mediators e.q~.. PPi, Pi, Cit, ATP, 
GTP, and DPG, show that ethoxyformic anhydride imparts 
increased stability to the protein with rate constants for 
the C-terminal site decreased by factors from 2 to 10. 
The largest effects were seen with intracellular iron 
chelators GTP and DPG. A protonated imidazole group near 
the metal perhaps serves as a binding site for the 
triphosphate chelators. The binding of such chelators to 
a nearby histidine may assist in the formation of a 
quaternary intermediate of the type
Chel-Fe-Transferrin-HCO^ prior to release of iron.
Modification using aquopentaamine ruthenium(I I ) a 
reagent for surface accessible histidine residues,
enhances the rate of release from the N-terminal site but 
has no effect the C-terminal site. The Tsou Chen-Lu 
statistical method used to analyze the rate data suggests 
the involvement of two histidines in the N-terminal lobe 
not conserved in the C-terminal lobe. These results may 
explain the kinetic lability of the N-terminal site 
relative to the C-terminal site in acidic solutions.
The distance between the metal site and nearby 
histidines was calculated from fluorescence energy 
transfer measurements using Tb(III) in the iron(III) 
binding site as the donor and pentaamine ruthenium(I II) 
modified histidines as the acceptor chromophore. The 
fluorescence measurements imply two histidines in each 
lobe are responsible for quenching of the Tb(III) 
emission. Using upper and lower limits for the index of 
refraction and quantum yield and assuming the energy 
transfer follows parallel first order kinetics, a 
donor-acceptor distance between 1.32 nm and 1.42 nm was 
obtained.
INTRODUCTION
Iron is an essential element for many metabolic 
processes including electron transfer reactions, 
deoxyribonucleotide synthesis and the transport and 
storage of oxygen. The major form of dietary iron 
absorbed in the intestine is iron(II). Once in plasma, 
the iron(II) becomes oxidized to iron(III). Under 
physiological conditions however, such "free" iron(III) 
forms insoluble ferric hydroxides which are toxic to 
biological systems. To circumvent this problem, nature 
has developed iron transport and storage proteins which 
form strong ferric complexes, thus avoiding the hydrolysis 
reactions inherent in the inorganic chemistry of 
iron!Ill).
Approximately 4 grams of body iron is distributed 
among the various iron containing proteins.3 Iron bound to 
hemoglobin accounts for sixty-five percent of the total. 
Twenty-five percent is contained in cytosolic and 
lysosomal ferritin, the storage protein for iron. 
Transferrin, the iron transport protein, accounts for less 
than one percent of the total iron distribution. However, 
all iron passes through transferrin at one time or another 
during its metabolism. Each molecule of transferrin 
cycles its iron an average of ten times in a twenty-four 
hour period and delivers about 100 iron atoms to 




The transferrins comprise a class of two sited metal
binding proteins distributed in blood and other bodily
fluids of all vertebrates and some invertebrates.3 The
three main types of transferrin are lactoferrin,
— 7ovotransferrin and serum transferrin. Ovotransferrin
found in egg white and lactoferrin of milk and other
secretions are bacteriostatic agents which deny invading
microorganisms the iron essential for their growth.3,9
There is -also evidence that ovotransferrin and lactoferrin
play a role in protecting cells from free radical damage
by sequestering catalytic iron.10 Serum transferrin, often
abbreviated as transferrin, transports metabolic iron
between sites of absorption, storage and utilization.
Other metals which bind to the transferrins include
Cu(II), Zn(II), VO(II), Mn(II), Cr(III), Tb(III) as well
as other members of the transition series, actinides and 
11-14lanthanides. Whether transferrin participates to a
significant extent in the transport and metabolism of 
these metals is unclear.
The transferrins are bilobal single chain 
glycoproteins having molecular weights near 80,000. They 
are capable of binding two iron(III) ions in separate N-
and C-terminal lobes or domains. In serum transferrin, 
42% of the amino acids are conserved between the two 
domains. The extensive homology between the lobes 
indicates that duplication and fusion of a structural gene
3
for a one-sited precursor transferrin occurred sometime 
during evolution.1'^
In order to bind iron appreciably, a synergistic 
anion, usually ibi)carbonate, needs to be present. This 
apparent cooperativity in binding is a property unique to 
transferrin. Another notable feature is the unusually 
high stability constant (lO^4 M - 1 )16 for the
iron-transferrin complex. Despite this strong binding, 
transferrin readily gives up its iron upon demand to 
cells. The understanding of this phenomenon lies in the 
elucidation of the mechanism of iron release and is the 
focus of much research in transferrin chemistry.
The proposed mechanism for iron uptake by cells
17 1 flinvolves receptor-mediated endocytosis. r Transferrin
first binds to a specific receptor on the outer cell 
19membrane. The transferrin-receptor complex then becomes 
incorporated into an acidic intracellular compartment, the 
endosome. Iron is subsequently released, possibly with 
the aid of chelating agents (e .cr. 2 ,3-diphosphoglycerate 
<DPG), adenosine triphosphate (ATP) or other phosphate 
compounds). Transferrin depleted of iron remains bound to 
the receptor and returns to the extracellular medium where 
it is released for another cycle of transport. The 




The x-ray structure of human lactoferrin has recently 
been determined at 0.32 nm resolution.20 The exact 
organization of the protein and the identity of the 
binding ligands is now known. The information obtained 
from the structure of lactoferrin can be used for serum 
transferrin and ovotransferrin since the complete amino 
acid sequences are known for all three proteins and they 
have many structural features in common.
The N- and C-terminal lobes are ellipsoidal with 
approximate dimensions 55 A x 35 A x 35 A and are 
connected by a three turn helix. The iron sites are 
buried in the lobes and are approximately 42 A apart. Each 
lobe can be separated further into two equal-sized 
domains, I and II, which describe the environment of the 
bound iron. Figure 1 illustrates the folding pattern and 
the relative orientation of the amino acid ligands. In 
the N-terminal lobe, residues 1-90 and 91-251 are folded 
in domains I and II, respectively. The chain then crosses 
back into domain I with residues 252-320. The same 
pattern is found in the C-lobe. Tyrosine-95 and Tyr-188, 
His-249 and Asp-63 are shown bound to the iron. The 
numbering of the residues corresponds to the N-terminal 
sequence. Previous magnetic resonance and chemical 
modification studies have suggested two or three tyrosines
5
Figure 1; Schematic representation of the complex folding 
pattern and relative orientation of amino acid ligands in 
the N-terminal lobe of transferrin. Adapted from 
reference 20.
6
21-24ct.nd one or two histidines as ligands to the metal.
The additional residues implicated as ligands in these 
studies but not found to be ligands by x-ray 
crystallography are presumably near the metal.
The electron density near the protein ligands suggest 
the presence of bicarbonate (or carbonate) and a water 
molecule to give an octahedral complex. The bicarbonate 
is positioned in the vicinity of Arg-124 in the N-terminal 
lobe and Arg-454 in the C-terminal lobe. These residues 
are thought to participate in bicarbonate binding to the 
protein, forming a bridge to the metal.
Iron Release
It is well established that iron release involves 
protonation of the iron-transferrin complex.'1' The rate of 
removal in the presence of chelators is first-order with 
respect to hydrogen ion concentration.2b Thus in acidic 
media, the rate of iron release is greatly accelerated. As 
the pH of diferric transferrin is lowered, iron is first 
released from the N-terminal site in the pH range 7.0 -
5.5 and then from the C-terminal site between pH 5.5 and 
4.0.27
The reduction in thermodynamic stability of the 
iron-transferrin complex cannot be explained solely in 
terms of reduced pH, however. In the absence of 
chelators, transferrin can retain iron as low as pH 5.7
7
suggesting chelators likely play a role in iron release
2 9from the protein in-vivo. Chelators mediate iron removal
from the protein in-vitro by interacting with the bound
iron, then removing and transporting it to a terminal
acceptor such as desferrioximine B which has a higher
affinity for iron than transferrin. Possible in-vivo
chelators which may serve an intracellular transport
function include ATP, DPG, guanosine 5-triphosphate (GTP)
and other phoshate compounds. Bates and coworkers have
proposed that the iron-transferrin-carbonate complex
becomes destabilized through a transition from a "closed"
to an "open" conformation, leaving the iron subject to
2 9attack by chelators. This mechanism is consistent with 
recent EPR and kinetic measurements indicating the 
formation of a quaternary mixed-ligand Chel-Fe-Tf-C03_ 
intermediate in the iron exchange reaction where 
pyrophosphate is the chelator.^0
Examination of the x-ray structure of diferric 
transferrin reveals complex folding patterns which 
envelope the iron in each lobe (Figure 1). When iron 
becomes bound to transferrin, a conformational change to a 
more compact ordered structure occurs where amino acid 
ligands from three different regions of the molecule 
arrange to coordinate the metal. In view of the 
complexity of the molecule, one may envision a series of 
events involving mediating chelators and protein 
functional groups which alter the thermodynamic stability
8
thereby triggering a conformational change.
Experiments with diferric transferrin in the presence 
of the sodium salts of anions have provided evidence for 
the involvement of cationic functional groups in the 
mechanism of iron removal, possibly serving as anion 
binding sites for chelators. Simple salts such as NaCl 
and NaClO^ alter the EPR spectrum of diferric transferrin 
showing that anion binding sites influence the metal 
centers."3* The presence of salts also affects the rate of 
iron removal from both sites. The rate of iron removal
decreases at the N-terminal site and increases at the
3  2C-terminal site with increasing salt concentration.
Different salts at the same ionic strength affect the rate
of iron removal differently, showing that the effect is
not solely due to changes in ionic strength. It is
significant that the rate of iron release for transferrin
chemically modified with acetic anhydride, a reagent
specific for lysines under mild conditions, shows a
similar trend, suggesting lysine as a potential anion
3 2binding site.
The e-amino group of lysine, the guanidium group of
arginine and the imidazole group of histidine are
functional groups near the metal site which may explain
the bicarbonate requirement for iron binding as well as
the effects of salt and pH on the thermodynamic stability
25or the protein. At physiological pH, arginine and lysine 
are cationic and probably contribute to iron release by
9
serving as binding sites for anions that can trigger
conformational changes. They could also function as
recognition sites, directing chelators to the iron,
leading to the formation of mixed ligand complexes.
The imidazole side chain of histidine is a prime
candidate for involvement in the iron release mechanism.
Histidine can serve as a base by transiently accepting a
proton and as an acid by transferring it again.
Similarly, histidine can be both a donor and acceptor in
hydrogen bonding. Clearly, interactions between
non-coordinated histidine residues and the surrounding
protein may well be important in the mechanism of iron
removal and merit further study.
The first definitive study implicating
non-coordinated histidines was done by Chasteen and 
34Williams. In this work the metal binding properties of 
transferrin were investigated using urea polyacrylamide 
gel electrophoesis (urea-PAGE). In the pH range 6 to 9 , 
the relative affinity of the two sites for iron followed 
typical pH titration curves. The results show metal 
binding is influenced by the deprotonation of functional 
groups with pK values near 7.4, typical of histidineA
residues. EPR studies show there is no change in the 
first coordination sphere of the metal indicating that the
groups involved are probably not coordinated to the metal.
35Thompson et a l . studied the effect of chemical 
modification of histidine on the iron removal properties
10
of transferrin. Chemical modification using ethoxyformic 
anhydride removes the positive charge on the imidazole 
side chain. By spectroscopically monitoring the rate of 
iron removal from the modified protein by chelators, 
increased kinetic stability of both the N- and C~ terminal 
sites was observed.
In the above kinetic study, the pool of reactive 
histidines in diferric transferrin were chemically 
modified to different extents. The Tsou Chen-Lu 
statistical method was used to analyze the rate data.^5 
The results implied that a single modified histidine in 
each lobe was responsible for the observed kinetic 
stability of the modified protein. Examination of the 
amino acid sequence for conserved histidines in both lobes 
reveal that His-119 and His-207 in the N-terminal lobe are 
near the binding site and have counterparts in the C-lobe. 
There are also conserved histidines further away from the 
binding site, such as HIS-242 in the N-terminal lobe, 
which cannot be excluded as candidates for the key 
histidine, however.
The goal of this research is to further elucidate the 
role of histidine in the mechanism of iron release from 
serum transferrin. Chapters 1 and 2 concern kinetic 
studies of transferrin chemically modified with 
ethoxyformic anhydride and aquopentaammine ruthenium(I I ). 
In chapter 3, energy transfer measurements are described
11
to determine the distance between the metal site and 
modified histidine residues. If the histidine is close to 
the metal binding site, its role may be to direct 
chelators to the iron, leading to the formation of a 
mixed-ligand complex. If the histidine is found to be 
further away, then an allosteric mechanism may be involved 
whereby the putative histidine triggers a conformational 




THE EFFECT OF MEDIATORS ON THE RATE 
OF IRON RELEASE FROM NATIVE AND 
ETHOXYFORMYLATED DIFERRIC TRANSFERRINS
INTRODUCTION
Much of the definitive work on the role of chelators
in the release of iron from transferrin has been carried
3 f t  — 3 f iout by Morgan and coworkers. Linear dependence on
CH+J in the pH range 6.0 - 7.5 was observed when chelators
3+mediated the transfer of Fe from transferrin to
desferrioximine B.^6 The mediators included ATP, GTP,
2,3-diphosphoglycerate (DPG), pyrophosphate (PPi), oxalate 
and other compounds known to be present within cells. In 
another study, intracellular pH was raised by adding 
agents such as ammonium chloride and methylamine to the 
culture m e d i u m . T h e  elevated pH inhibited iron 
release, consistent with the requirement for protonation 
of the iron-transferrin complex in-vivo.
Attention has been focused recently on
non-coordinated amino acids of transferrin which may play 
a role in the iron release m e c h a n i s m . ^ ^  Thompson used 
ethoxyformic anhydride (EFA), a reagent specific for 
histidine, to chemically modify diferric transferrin. The 
modification reaction is shown below.
P_0  + +  EtOH +  CO.
14
The kinetics of iron removal at pH 7 were studied on 
diferric transferrin samples ethoxyformylated to different 
extents. Pyrophosphate was used as as a mediator and 
desferrioximine B as a terminal iron acceptor. The
results indicated that modification significantly
decreased the rate of iron removal relative to the native 
protein.
In the present study the chelating mediators DPG, 
citrate(Cit) GTP, ATP, orthophosphate (Pi) and PPi were 
employed in the iron release reaction of EFA modified 
transferrin. These experiments were performed at pH 5 to 
mimic the conditions of the acidic endosome within the
cell where iron release takes place. In every case,
protein modification slowed the rate relative to the 
native protein hy factors ranging from 2 to 10, thus 
showing that the results of Thompson were not simply due 
to choice of the mediator P P i . ^ ' 4^
15
MATERIALS AND METHODS
All chemicals were reagent grade and used without
further purification unless otherwise stated. Glassware
was washed with 6 M HC1 and rinsed thoroughly with doubly
distilled and deionized water (D/D H 20) before use.
Sources of reagents were:
Human serum transferrin - Calbiochem-Behring
Sodium bicarbonate, NaHCO^ - Baker Analyzed Reagents
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic 
acid) - Research Organics stored over Chelex 100.
MES (2-(N-morpholino)-ethane sulfonic acid ) - Sigma
Ferrous ammonium sulfate hexahydrate,
Fe(NH4 )2(S04 )2’6H20 - Baker Analyzed Reagents
EFA (ethoxyformic anhydride), " Aldrich
Sodium perchlorate, NaClO^ - Baker Analyzed Reagents
Desferrioximine B, C26H 52N6°11S - ciba
Sodium pyrophosphate decahydrate, Na.P 07 ‘10H,0 
-Aldrich 4 1 1
Sodium citrate pentahydrate , Na,Cc-He-07 * 5H70 
-Mallinckrodt j b o / z
Sodium phosphate dodecahydrate, Na_HF0.*12H^0 - Sigma« *1 £*
ATP (adenosine triphosphate) - Aldrich 
GTP (guanosine 5'-triphosphate) - Sigma 
DPG (2,3-diphosphoglycerate) - Sigma
16
Transferrin
Iron-free, lyophilized human serum transferrin (500 
mg) of stated. 98-99% purity was dissolved in 5 mL of D/D 
^ O .  To eliminate reducing agents non-specifically bound 
to the protein of commercial preparations, the protein 
solution was then dialyzed against three changes of 0.10 M 
sodium perchlorate pH 7.0 - 8.0, followed by three changes 
of 0.010 M HEPES and 0.010 M NaHC03 at pH 7.5 - 8.0 (2 L 
per change). The concentration of apotransferrin was 
determined spectrophotometrically with a Cary 219A or 
Bausch and Lamb 505 spectrophotometer using a molar 
absorptivity, e280nm = 8.89 x 104 M_1cm"1 .43
Diferric transferrin in 0.10 M HEPES and 0.020 M 
NaHCO^ was prepared by adding 0.01 M ferrous ammonium 
sulfate in 0.01M HC1 to the transferrin solution to 97% 
iron saturate the protein. The solution was left to 
equilibrate for 10 - 12 hours to ensure maximum binding of 
the iron. The final degree of saturation achieved was
determined by measuring the absorbance at 465 nm using
- 1 - 1  7
e465nm = ^000 ^ cm molecule of diferric protein.
Typical levels of saturation obtained were 77 - 91%.
Ethoxvf ormvlat ion
Ethoxyformic anhydride (EFA) was gradually added in 
microliter amounts to a stirred solution of 3.8 - 4.0 nM 
diferric transferrin in 0.10 M HEPES, 0.10 M NaHCO^ at pH
7.4, to a final concentration of 1.0 - 2.0 mM EFA. The
17
modification reaction was monitored by uv difference 
spectroscopy at 242 nm with native diferric transferrin in 
the reference cell. The extent of modification was 
calculated using a molar absorptivity e242nm = 3200
M 1cm per histidine monoethoxy- f o r m y l a t e d . L o w  
molecular weight products were removed by ultrafiltration 
using an Amicon cell fitted with a PM10 membrane having a 
molecular weight exclusion limit of 10,000. The volume 
was replaced three times (90% V/V per change) with fresh 
0.01 M HEPES at pH 7.0 - 7.4.
Iron Release Reaction 
The rate of iron removal from native and 
ethoxyformylated diferric transferrin was monitored at 295 
nm using a Cary 219A spectrophotometer interfaced with an 
Apple lie computer. The sample cells were thermostatted to 
25.0°C ± 0.1°C. The cells were optically balanced at 295 
nm using D/D H^O. The D/D H^O in the sample cell was then 
replaced with 1.2 mL of 12 - 20 pM protein in dilute 5 mM 
HEPES at pH 7.0. A reaction solution (68 pL) of 0.10 M 
mediator (sodium salts of C i t , PPi, Pi, ATP and DPG), 0.02 
M desferrioximine B in 1.0 M MES at pH 5.0 was added to 
the the sample and reference cuvettes to obtain a final 
concentration of 3 mM in mediator. When GTP was used as 
the mediator, a reaction solution (68 pL) of 2.0 mM GTP, 
0.20 M desferrioximine in 1.0 M MES was used and added to 
both cells (1.0 mL) giving a final concentration of 1.20 x
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— 410 M GTP. The decrease in ahsorhance as a function of 
time was typically recorded using Apple lie kinetic
sof tware.
The pseudo first-order macroscopic rate constant for 
iron removal from the C-terminal binding site, k^, was 
determined by linear regression using Equation 1.
'*'n ^ 2 9 5  A oo> — A o ” A oo^  V  (E q . 1)
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RESULTS
Kinetic studies were carried out on completely
modified transferrin in order to deactivate the histidine
residues involved in the iron release reaction.
Concentrations of ethoxyformic anhydride ranging from 1.3
1.5 mM resulted in the modification of 14.0 - 15.1
histidine residues on diferric transferrin at a
concentration of 4|jM. The values obtained here for
extensively modified transferrin are consistent with those
24 41previously reported. ' (Out of IB total residues, ^4
histidines on diferric transferrin are unreactive toward 
EFA.)35
Ethoxyformylation had the greatest effect on the rate 
of iron removal when 2 ,3-diphosphoglycerate (DPG) was 
employed as the mediating chelator. The increased kinetic 
stability is shown in absorbance vs. time curves for
native and modified transferrin using DPG (Figure 1). The 
times for removal of 90% of the iron from the protein are
3.0 min and 23 min for native and modified transferrin,
respectively. The macroscopic rate constant for the 
C-terminal site was extracted from semilogarithmic plots 
(Figure 1.2). All six mediators showed similar biphasic 
kinetics, however, iron removal from the N-terminal site 
was too fast to obtain a reliable macroscopic rate 
constant for this site using conventional spectro­
photometry.
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Ficrure 1.1: Time course of the iron release reaction at
295 nm for native (A) and modified (B) protein using
2,3-diphosphoglycerate (DPG) as chelating mediator. 
Conditions: (A) 16.0 pM native diferric transferrin, 3„mM 
DPG, 1.3 mM desferrioximine B, 0.064 M MES, pH 5.20, 25 C. 
(B) 18.0 pM modified transferrin (14 histidine residues 
ethoxyformylated), pH 5.19, same conditions as curve (A). 
The arrows indicate the times for 90% iron removal. FILES: 
DPGNAT, DPGMOD, Disk: #1.
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The macroscopic rate constants for the C-terminal 
site for 90% iron removal from native and modified 
transferrins by various mediating chelators are listed in 
Tables I and II. Overall, the rates are markedly faster at 
pH 5 when compared with previous studies at pH 6.9 
conducted under otherwise similar conditions of 5 mM
oe ■qg
mediator and 5 mM desferrioxime B. r
The relative rate of iron removal in native 
transferrin at pH 5 under the action of 6 different 
mediators follows the order GTP > DPG > PPi > ATP > 
citrate > Pi. In contrast, the relative rates for modified 
transferrin in Table II follow the order PPi > GTP > ATP > 
citrate ^ phospate > DPG. Ethoxyformylation imparted the 
greatest rate differences when DPG and GTP are used as 













Figure 1.2: Semi logarithmic plot of In - A > vs.
time for the iron removal of modified transferrin using
2,3-diphosphoglycerate (DPG) as mediating chelator. 
Conditions: 18.0 pM modified diferric transferrin (14.0 
His modified), 3 0mM DPG, 1.3 mM desferrioximine B, 0.064 M 
MES, pH 5.19, 25 c. The macroscopic rate constant for the 
C-terminal site, fc was measured by linear regression on 
the linear portion of the second phase of the above plot 
employing the last 8 points. The N-terminal site was too 
fast to obtain a rate constant using conventional 








Time for 90% Fe 
Removal (min) pHC
citrate 0.18 + 0. 01 5.3 5.11
0 .18 ± 0.01 5.6 5.14
phosphate 0.14 ± 0.01 8.0 5. 05
0.16 + 0.02 12.6 5.12
0 .16 ± 0. 01 12.6 5.14
pyrophosphate 0.55 0. 05 2.1 5.12
0.55 + 0. 03 2.2 5.14
ATP 0. 34 ± 0. 04 2.5 5. 00
DPG 0.69 + 0.03 3.0 5. 20
GTPd 0.90 + 0. 08 1.0 4. 77
aConditions: 12.0 - 20.0 |jM native diferric transferrin 
1.3 mM desferrioximine B, 0.064 M MES, 3 mM mediator
25.0 ± 0.1°C.
^Replicate determinations shown. Confidence intervals 
for the standard deviation of the slope given at the 95% 
probability level.
cMeasured at completion of the reaction.
d. "The concentration of GTP was diluted 50-fold relative
to the other mediators due to its high absorbance 
at 295 nm. Fifty-fold dilution for di- and tri­
phosphate mediators decrease the rate of iron removal 
by factors ranging from 2 to 4. The rate constant has 
been corrected by assuming a 50-fold dilution will 







Time for 90% Fe 
Removal (min) pHC
citrate 0.11 i 0.01 12. 0 5.03
0.093 ± 0.01 12.0 5.12
phosphate 0.11 ± 0.01 26.0 4.80
pyrophosphate 0.23 ± 0.02 9.5 4.99
0.24 ± 0.04 9.5 4.99
ATP 0.11 ± 0.01 13.0 4.98
0.16 ± 0.03 11.4 4. 98
DPG 0.055 + 0.002 23. 0 5.19
GTPd 0.20 ± 0.02 12.7 4.67
Conditionsi 12.0 - 20.0 pM modified diferric transferrin 
(14.0 - 15.1 His residues ethoxyformylated), 1.3 mM 
desferrioximine B, 0.064 M MES, 3 mM mediator
25.0 ± 0.1°C.
^Replicate determinations shown. Confidence intervals 
for the standard deviation of the slope given at 
the 95% probability level.
Q
Measured at completion of the reaction.
dThe concentration of GTP' was diluted 50-fold relative 
to the other mediators due to its high absorbance 
at 295 nm. Fifty-fold dilution for di- and 
tri-phosphate mediators decrease the rat;e of iron 
removal by factors ranging from 2 to 4.* The rate 
constant has been corrected by assuming a 50-fold 




The kinetic experiments described demonstrate that 
the decrease in the rate of iron release when the protein 
is modified is not unique to the mediator pyrophosphate
a
employed in previous studies. ' Indeed the effect is
seen with a variety of mediators (Tables I & II) and
supports the hypothesis that histidine residue(s) play a
role in the mechanism of iron removal from transferrin.
The relative order of the rates of iron release with
different mediators is in accord with the work of others.
The kinetic studies of Carver and Friedman at pH 6.1 gave
the following order for both sites: PPi > GTP ^ ATP ^ DPG 
4 5
> uit > Pi. The rate of chelator-mediated iron exchange 
at neutral pH between rabbit and human transferrin 
followed the order GTP > DPG > ATP > Cit > PPi > Pi. 
Except for PPi, the order parallels the rates observed in 
the present study at pH 5. The high affinity of PPi for 
iron, relative to the other mediators, perhaps explains 
the low rate of iron exchange with pyrophosphate.36
The most effective mediators were DPG, ATP and GTP 
which are present in mM concentrations in iron requiring 
cells.4 5 '46 of particular interest is the marked effect 
that ethoxyformylation of histidine has upon DPG and GTP 
in releasing iron from transferrin. The results are 
consistent with the idea that a protonated imidazole group
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near the metal serves as a binding site for the larger di- 
and triphosphate mediators. This would account for the 
more pronounced effect of modification on iron release 
when DPG, ATP and GTP are used as mediators. The 
neutralization of positive charge on the imidazole group 
resulting from EFA modification would inhibit the binding 
of these anionic chelators to histidine. Binding of 
chelators to the imidazole group of histidine possibly 
assists in the formation of a Chel-Fe-transferrin-CO^ 
intermediate complex which subsequently releases iron as a 
Chel-Fe complex where Chel is GTP, ATP or DPG. The 
presence of ATP and GTP iron complexes in red blood cells 
lends support to this mechanism.4^'48 These complexes are
stable at physiological pH and have strong formation
£
constants in acidic media (e.cr. KFe-ATP ^ 4 x 10 at
4 92). Their stability in acid makes them capable of 
forming in the acidic endosome and provide a means for 
intracellular iron transport at physiological pH as well.
While a histidine effect has been reasonably well 
established from in-vitro experiments in this laboratory, 
direct evidence for the involvement of non-coordinated 
histidine in the cellular uptake of iron within the cell 




EFFECT OF Ru(III) MODIFICATION OF NON-LIGANDED 
HISTIDINES ON IRON RELEASE
INTRODUCTION
The chemistry of ruthenium*II) and ruthenium*III) 
amine complexes has been an area of considerable activity 
in recent years. Several ruthenium compounds have been 
shown to interfere with DNA synthesis and exhibit 
anti-tumor activity in animals.50,51 Pentaammine
ruthenium*III) complexes have been used to investigate
5 2conformational changes in proteins. Electron transfer 
reactions of metalloproteins using pentaammine ruthenium 
bound to histidine as a redox-active metal complex have
c  t  _  pr q
also been carried out.
Reactions involving aquopentaammine ruthenium and 
model compounds, in neutral and acidic aqueous solutions 
give octahedral pentaammine-histidine complexes where
bonding is through the N-3 nitrogen of the imidazole ring
5 9(Figure 2.1). Titration with sodium hydroxide results in
intense charge transfer bands at pH 10. In aqueous
solutions which are not strongly acidic, pentaammine
ruthenium complexes of 7r-acceptor ligands like histidine
are relatively unreactive and undergo substitution very
6 0
slowly or not at all. The slow ligand exchange rate is 










Figure 2.1; Structure of pentaammine rutheniumtIII)- 
histidine complex formed from reaction between histidine 
and aquopentaammine ruthenium(I I ). Optical and NMR 
studies indicate bonding through the N-3 "pyridine 
nitrogen" of the imidazole ring resulting in charge 
transfer bands at 365 and 600 nm at pH 10 . Figure
adapted from reference 66.
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Several chemical modification studies involving 
aquopentaammine rutheniumtII) and proteins demonstrate 
that the reagent has a strong preference for surface
accessible histidine residues.^1/65 Other nucleophilic
groups such as lysines and methionines are potential 
candidates for roodification. However, under the mild 
conditions employed in these studies, aquopentaammine 
rutheniumtII) reacts only with imidazole moieties.
Matthews and coworkers have modified histidines in 
ribonuclease A6 '1', oc-Lytic protease^, and lysozyme.^2 Gray 
et a l . studied the effects of histidines modified with 
aquopentaammine rutheniumtII) in horse heart
ferricytochrome c®^, pseudomonas aeruginosa azurin^^, and 
sperm whale myoglobin.®^
In this chapter studies of the ruthenium modification 
of histidines on diferric and C-terminal transferrins are 
described. The results show that modification kinetically 
destabilizes the N-terminal site whereas modification does 
not significantly affect the C-terminal site. The data 
implies two non-coordinated histidines in the N-terminal 
domain are responsible for the observed kinetic effects.
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MATERIALS AND METHODS
All glassware was soaked in 6 M HC1 and thoroughly 
rinsed with doubly distilled, deionized water. Sodium 
perchlorate and HEPES were treated with Chelex 100 before 
use. Chelex 100 (Sigma, sodium form dry mesh 50-100) was 
made to the hydrogen form by passing copious amounts of
1.0 M HC1 through a fritted glass funnel, followed by 
rinsing with 0.10 M prechelexed NaOH. The pH of the 
effluent was adjusted to 6 by washing with D/D H^O. All 
chemicals were reagent grade, unless otherwise stated, and 
obtained from the following sources.
TRIS-HC1(Tristhydroxymethyllaminomethane hydrochloride) 
-Sigma
Sodium perchlorate - Aldrich 
Nitrilotriacetate (disodium salt) - Sigma 
Chloropentaammine ruthenium dichloride - Alfa 
Cesium chloride (ultra-pure) - Sigma 
Iron AA standard - Fisher Scientific 
Ruthenium AA standard - Aldrich 
Zinc metal granular 20 mesh - Mallinckrodt 
Mercury metal (triply distilled)
Argon (research grade 4.8) - Airco
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Transferrin
Iron-free human serum transferrin was prepared and 
assayed as described in Chapter I. Diferric transferrin 
(0.2 - 0.4 mM) was prepared by addition of 5.00 mM
iron(III):nitrilotriacetate (1:2) F e (N T A )2 , pH 4.0, 
calculated to 100% saturate the protein. Excess NTA was 
removed by dialysis against three changes of 0.10 M
NaClO^, 0.01 M HEPES, pH 7.0 - 8.0, followed by three
changes of 0.020 M HEPES pH 7.0 - 7.4. The percent
saturation (35 - 93%) was determined spectrophoto- 
metrically using the molar absorbtivity e4 6 5 nm 3 2500
M cm per bound iron. The percent destribution between 
the N- and C-terminal sites was determined by 
urea-polyacrylamide gel electrophoresis (UREA-PAGE) using 
the method of Chasteen and Williams.^4
C-terminal raonoferric transferrin was prepared by 
performing a preliminary difference titration using a CARY 
219A spectrophotometer. The cells were balanced with 0.1 
mM apotransferrin in 0.10 M HEPES and 20 mM NaHC03 , pH 7.3 
- 7.4. Microliter aliquots of Fe(NTA)2 were added to the 
sample cuvette and the absorbance scanned between 460 
470 nm. After determination of the titration endpoint, 
Fe(NTA)2 was added to a 0.2 mM stock apotransferrin 
solution in 0.10 M HEPES, 0.020 M NaHC03 pH 7.3 - 7.4 to 
47% saturate the protein. Excess NTA was removed by 
dialysis against 0.10 M NaC104 in 0.010 M HEPES, pH 7.3 -
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7.4, followed by dialysis against 0.025 M HEPES pH 7.3
7.4. The purity of the C-terminal preparation was 
determined using urea-PAGE as previously described. The 
stock monoferric solution was then frozen until further 
use.
Modification of Histidine 
The modification of histidines on diferric 
transferrin using the aquopentaammine ruthenium<II) 
reagent proceeds in three steps.
Ru(III) <NH3 )s C 1 (s) Zn^ -? ■> Rut II) (NH3 )5H20 (Eq. 2.1)
Rut II)(NH3 )5H 20 £££__> Ru(II)(NH3 )5-HIS + H 20 (Eq. 2.2)
Rut II) (NH3 )5-HIS ^ — > Rut III) (NH3 ) 5-HIS (Eq. 2.3)
The aquopentaammine rutheniumtII) reagent was
\
generated by reduction of chloropentaammine rutheniumtIII) 
dichloride using a Zn/Hg amalgam. The reduction and 
subsequent modification was performed under a continuous 
purge of argon to prevent the aquopentaammine
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rutheniumtII) complex from reacting with molecular 
nitrogen.
The amalgam was prepared by grinding 7.2 grams of Zn
flakes with 78 grams of Hg in 10 mL of 0.5 M H 2S04 with a
6 7mortar and pestle. The acid was decanted and the amalgam 
washed three times with D/D H20 and once with 0.250 M 
HEPES, pH 6.8 - 6.9, and then transferred to a 250 mL
round bottom flask. Chloropentaammine rutheniumtIII) 
dichloride t50 - 200 mg) in 20 - 125 mL of 0.250 M HEPES, 
pH 6.8 - 6.9 was added to the amalgam. Chloropentaammine 
Rut III) is insoluble in aqueous solution and dissolves 
only upon reduction. The reaction is complete when a 
clear bright yellow solution is obtained. Reaction time 
is typically 2 - 3  days.
The aquopentaammine Rut II) complex is decanted into a 
250 mL three-neck flask equipped with a spin bar. 
Twenty-four mL of 100 pM diferric or C-terminal 
transferrin in 0.250 M HEPES pH 6.8 - 6.9 is divided into 
4 mL aliquots and placed into dialysis bags. The reduced 
ruthenium complex readily diffuses through and reacts with 
the protein. The protein in the dialysis bag is removed 
from the ruthenium solution after various times {3 hours 
to 4 days) and the Rut II) oxidized by placing the dialysis 
bag in 1 L of a 0.250 M TRIS solution, pH 7.0, with 
aeration for 12 hours. This procedure oxidizes the 
rutheniumtII)-HIS complex to the stable trivalent state 
and removes the unreacted ruthenium reagent. Following air
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oxidation, the protein <^4 mL) is centrifuged and 
subsequently dialyzed against two changes (2 L each) of 
0.010 - 0.020 M TRIS pH 7.0 and once against 2 L of 0.010
- 0.020 M HEPES pH 6.8 - 7.0.
EPR Measurements 
EPR measurements were made on solutions frozen at 77 
K with a Varian E-4 spectrometer equipped with a liquid N 2 
dewar inset. Instrumental settings were:
Field Set = 1500 G
Scan Range = 2000 G
Modulation Amplitude = 8.2 G
Time Constant = 1.0 s
Microwave Power = 10 mW
Scan Time = 8 min
No. of Data Points = 2000
Double integral values were calculated from spectra 
to which a linear baseline correction had been applied.
Iron-Free Modified Transferrin 
Iron-free modified transferrin was prepared from 50 
mM protein upon addition of pyrophosphate, desferrioximine 
B and MES buffer with final concentrations 50 mM, 3 mM and 
0.10 M respectively. The pH of the solution was adjusted
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to 5.0 with 0.1 - 0.5 M HC1 and allowed to equilibrate for 
10 - 12 hours. In order to quantitatively remove iron,
the protein was exhaustively dialyzed using five changes 
of 0.010 M TRIS pH 6.8 - 7.0 (2 L each) followed by 2 L of 
0.010 M HEPES pH 6.8 - 7.0. The extent of iron removal
from the protein was determined by EPR measurement of the 
g'= 4.3 signal. The modified apoprotein was assayed 
spectrophotometrically at 280 nm using a molar
absorptivity of £280nm = 8,89 x 1q4 M -1cm~1.43
Quantification of Modified Histidine Residues 
The concentration of Ru in Ru{III)(NH.,)C-HISJ D
transferrin was determined by measurement of the 372.8 nm
Ru emission line using a nitrous oxide-acetylene flame. An 
Instrumentation Laboratories IL 951 dual channel AA/AE
spectrometer was used for the analysis following an
68established protocol. Optimum signal was obtained using 
instrumental parameters described in Table III. Channel B 
measured emission intensity at 3 72.8 nm. Channel A  was
set 1.3 nm from the analytical line and was used to
monitor background emission.
Cesium chloride (1000 ppm) was added to all samples 
and standards in order to suppress ruthenium ionization. 
Optimization of emission intensity was done using a 20 ppm 
RuCl^ standard and a blank containing 1000 ppm CsCl and 
D/D ^ O .  ■^ ie Paranieters varied were wavelength, burner 
height and fuel-oxidant ratio. It is critical to operate
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with very lean fuel, otherwise complete quenching of the 
signal occurs due to intense background emission from 
cyanogen at 365 - 390 nm, characteristic of a fuel-rich 
flame. During optimization and analysis the burner head 
was periodically scraped to avoid clogging.
A calibration curve was established for each run 
using a series of seven standard RuCl^ solutions in the 1 
- 50 ppm range. The standard addition method was used to 
compensate for chemical interference arising from the 
protein matrix. A three or four point standard curve was 
generated for each protein analyzed, the amount of added 
Ru ranging from 0 - 3  ppm. Typically, 2 - 10 pM of
modified apoprotein (1.25 mL) was aspirated into the
flame. The concentration of protein employed was chosen 
to minimize sample consumption for the extent of ruthenium 
modification of each sample.
Samples, standards and blanks (one blank per four 
samples) were run in random order. Readings were taken in 
triplicate with each reading averaged over 2 - 3  seconds. 
The mean standard deviation and relative standard
deviation were calculated by the IL 951 microcomputer. 
Linear regression for the generated standard addition
curve was performed on each sample. The histidines
modified per mole of transferrin was then calculated.
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Table III
Atonic Emission Instrumental Parameters3
Burner Head : ^ 0  single-slot standard burner head 
Flame Description : ^ O - a c e t y l e n e , fuel lean with 5 mm red
feather
Fuel/Oxidant : 0.70 
Aspiration Rate : 5.2 - 5.4 mL/min 
Burner Height : variable 
Scale Expansion : 1.0











IL 951 Instrumentation Laboratories AA/AE Spectrometer
Alternate emission wavelengths for Ru are 379.9 nm, 349.9 nm 
and 342.8 nm.6®
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The formation of Ru(III)(NH^)^-His complex was 
determined by uv/vis difference spectroscopy Apo- 
transferrin (6 yM) at pH 10.0 was balanced in both the 
sample and reference cells. Modified apoprotein (pH 10.0) 
at the same concentration was then substituted in the 
sample cell and the absorbance scanned from 500 nm to 325 
nm. The molar absorptivity used for calculation was 
E365nm = -3350 M ^cm ^ Per Ru-His formed.59
Iron Release Reaction 
The rate of iron removal from native and Ru modified 
transferrin was monitored at 295 nm using a CARY 219A 
spectrometer thermostatted to 25.0 °C ± 0.1 °C. The cells 
were initially balanced at 295 nm using 0.10 M HEPES, pH 
7.0. The sample cell was then replaced with 1 0 - 1 5  yM 
protein in 0.10 M HEPES at the same pH. A reaction 
solution of 0.10 M pyrophosphate and 0.020 M 
desferrioximine B was added to the sample and reference 
cells to obtain a final concentration of 3 mM in 
pyrophosphate. Absorbance v s . time curves for diferric 
proteins were fitted to Equation 2.4 using RS-1 software 
on the VAX 11/780 computer.
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a295 = (Ao ” A^XXjjexpt-lCjjt:) + Xcexp(-kct)) + A°° (Eq 2.4)
where %  and k^ are the pseudo-first order 
macroscopic rate constants for iron removal from the N- 
and C-terminal sites. X^ and are the mole fractions of 
iron in the two sites. For C-terminal transferrin, a 
linear regression was used to determine the macroscopic 
rate constant using Equation 1.1 in chapter I.
A Tsou Chen-Lu plot was used to analyzed the kinetic
data for the N-terminal site. The Tsou Chen-Lu method is
a graphical technique used to determine the number of
essential residues responsible for a change in activity in
€\ Qa chemically modified protein. The activity, a, can be 
any experimental quantity. The relationship is given by 
a 1/:L = X, where a is the activity and X is the mole
fraction of unmodified residues in a pool of equally
reactive residues. A linear plot of a 1^  vs. X is
obtained upon proper choice of i. (i = 1, 2, 3,....), the




In addition to the procedure described in the methods
section, preliminary experiments included reducing the
Ru(III) salt electrocheraically using Pt electrodes held at
a constant potential of 1.2 volts. This reduction
procedure led to undesirable side reactions observed by
the absence of yellow color due to the Ru( II > (NH-,) _Hn0
j o 2
species and by the presence of brown precipitate at 
reaction times greater than 6 hours. This procedure 
therefore was not studied further.
Reduction of Ru(III)(NH^)^C1 using a Zn/Hg amalgam 
proceeded successfully, producing a bright yellow solution 
in 2 - 3 days. After solubilization of the Ru(III), salt 
the reaction went through an intermediate peach color 
presumably due to the formation of C R u ^ ^  ^
The conditions employed here (Materials and Methods) 
modified 6.0 histidine residues per mole of diferric 
protein and 8.1 histidines per mole of C-terminal 
monoferric transferrin for 48 - 60 hr reaction times.
Protein exposed to longer reaction times produced 
considerable precipitate. Analysis by EPR and
spectrophotometry indicated that a significant amount of 
Fe did not remain bound to the protein at reaction times 
greater than 60 hours. Long reaction times also led to
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the appearance of an unknown band occurring at 270 - 300
nm. The band could be due to modification of
69methionines; however, this assignment has not been 
verified. Due to the difficulties encountered with long 
reaction times, diferric and C-terminal monoferric 
transferrin are said to be extensively modified at values 
of 6.0 and 8.1 per mole. of protein, respectively, 
corresponding to reaction times of 'V50 hr.
The number of residues modified per mole of 
transferrin was determined using atomic emission 
spectrometry with background correction (Materials and 
Methods). A typical working curve for Ru at 372.8 nm is 
shown in Figure 2.2 for a fuel-lean nitrous oxide 
acetylene flame. The linear range varied from 0 - 5.8 ppm 
to 0 - 1 0  ppm between runs, however. Quantification by 
the working curve method gave positive deviations due to 
the physical and chemical interferences arising from the 
protein matrix. Therefore, the standard additions method 
was chosen to measure Ru in the protein (Figure 2.3).
Characterization of the Modified Complex 
The formation of the pentaammine ruthenium-histidine 
complex in diferric transferrin was determined by 
comparing the optical spectra of modified apotransferrin 
with that of pentaammine ruthenium-histidine trichloride,
cq
a model for the transferrin complex. The difference 
spectrum of iron-free Ru modified (6.0 His residues) vs.
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Figure 2.2: Calibration curve of emission intensity v s . 
ppm ruthenium for the 327.8 nm analytical line (see 
Materials and Methods). The linear portion of this curve 
is from 0 to 10 ppm. This linear range varied between 
runs. Quantification of bound ruthenium in the protein 
matrix gave positive deviations with the working curve 
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ppm Ru (III) added
Figure 2.3; Standard additions plots for the
quantification of ruthenium in transferrin. Linear portion 
of the working curve used (see Materials and Methods). 
Shown are typical standard addition curves which were 
generated for each transferrin sample analyzed. Linear 
regression shows 1.72 ppm (3.4 modified residues) for A 
and 0.339 ppm (0.425 modified residues) for B.
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native protein at pH 10 is shown in Figure 2.4. An 
intense band occurs at 377 nm and a broader, less intense 
band is found from 510 - 620 nm. Bands of similar
intensity and width are found for the model compound at 
365 and 600 nm at pH 1 0 . ^  The bands are due to
ligand-to-metal charge transfer transitions between the 
deprotonated imidazole and the ruthenium. The bands for 
protonated imidazole on the model compound are less
intense and occur at 303 nm and 450 nm at pH 5. A pK of
cL
598.87 for the nitrogen on imidazole has been reported. 
The pH behavior observed for modified transferrin is 
consistent with the spectral shift of the model compound.
No change in the optical spectrum occurred upon 
ultrafiltration (3 changes of fresh 0.01 M HEPES, pH 7, 
90% V/V each change) or upon storage at pH 7 at 4°C for 6 
weeks. Long terra stability of the modified protein is in 
accord with ruthenium amine complexes stored in aqueous 
solution at neutral pH (ruthenium complexes of ir acceptor 
ligands such as imidazole are labile and can undergo 
ligand substitution under acidic conditions, however).
Little difference is observed in the characteristic 
g'= 4.3 EPR signal between native and modified diferric
transferrins, indicating that no gross changes in the Fe 
binding sites occur upon modification (Figure 2.5). 
Comparison of linewidths show no paramagnetic line 
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Figure 2.4; Difference spectrum of iron-free pentaammine 
rutheniumtIII) histidine transferrin against apotransferrin 
from 330 nm to 650 nm. Conditions: 3.65 pM modified (6.03 
residues) and native protein, pH 10.0. An intense band 
occurs at 377 nm and a broader, less intense band is found 
at 555 nm. The observed peaks are consistent with the 
pentaammine ruthenium-histidine trichloride model compound 
at pH 10.0. No change in the above spectrum is apparent 
after ultrafiltration or storage at 4°C, pH 7, for 6 weeks. 
FILES DS1, DS2 and DS3 Disk #3.
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Ficrure 2.5; g'=4.3 EPR signals of diferric {^.20 mM) (A) 
and .08 mM modified(1.46 His residues) (B) transferrin in 
100 mM HEPES, pH 7.0. Instrument settings are given in 
the Materials and Methods section.
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Spectrophotometrie titration at 295 nm of Fe(NTA >2 
into iron-free modified protein (2.0 His/mole) shows
ruthenium modification did not affect the iron binding
properties of transferrin at pH 7.5 (Figure 2.6). A clear
break is seen at 2.05 moles Fe per mole of transferrin.
Assuming two moles of iron bound to the protein, a prior
assay at 280 nm indicates the molar absorptivity of the
modified protein is 2.5% higher (9.11 x 10^ M -1cm-1 at 280
nm) than the native value of e-,on = 8.89 x 104 M -1cm-1.280
The Iron Release Reaction 
The semilogarithmic plot for absorbance vs. time data 
in the iron release reaction for native diferric and 
ruthenium modified transferrins (1.5 histidine residues) 
using pyrophosphate as the mediator is shown in Figure 
2.7. The reaction is clearly biphasic at pH 7. The two 
macroscopic rate constants were extracted from the 
experimental curves using Equation 2.4 (Materials and 
Methods). The rate constants, k^ and k^ ,, obtained for 
modified protein were 0.060 min-1 and 0.013 m in-1. The 
values obtained for native protein under the same
conditions were k^ = 0.037 min-1 and = 0.016 min-1. In 
contrast to diferric transferrin modified with 
ethoxyformic anhydride, the rate of iron removal at the 
N-terminal site increases with increasing ruthenium 
modification. The rate of iron release from the 
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n m . r e  2.6: Titration of FetNTA), into ir°n-free n^ifi-ed 
transferrin (2.0 His residues modified). Conditions. 20 
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Figure 2.7: Semilogarithmic plot for absorbance data at
295 nm for the iron release reaction as a function of time 
at 25°C. Conditions: A - 17.8 yM native protein in 5 mM
P P i , 0.10 M HEPES and 1.0 mM Des, pH 7.16. 0 - 17.0 yM 
two plots. The k_ values are the same for native and 
modified proteinsr FILE: SPNAT, SPM2 Disk#3.
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modification, however. Measurements were also made on 
native and modified C-terminal protein showing that the 
smaller rate constant was for the C-terminal site.
Iron release studies on a series of transferrins with 
varying degrees of ruthenium modification were carried 
out. The %  rate constants extracted from the kinetic data 
are shown in the form of a Tsou Chen-Lu plot (Materials 
and Methods) in Figure 2.8. The activity parameter, a, is 
defined in terms of the macroscopic rate constants, k^, 
kp, and k^ for the unmodified, partially modified, and 
extensively modified protein, respectively
( a= < i^-kp) / ( ku-km ) ) . A linear plot results for a ^ *  vs. X
when i = 2 and i = 3, whereas the data for i = 1 and i = 4
(not shown) are curved. The results imply that 
modification of two or three histidines is responsible for 
the increased kinetic stability of the protein with iron 
in the N-terminal site.
Q 7
The F-test as applied to the macroscopic rate
constants obtained for the C-terminal site for five 
C-terminal monoferric transferrin samples (4 modified, 1 
native) and seventeen diferric transferrin samples (14 
modified, 3 native). In all cases k^ was not
significantly different at a 95% confidence level implying 
that the C-terminal rate is unchanged upon modification.
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Ficrure 2.3; Tsou Chen-Lu plots for kinetic data for the 
N-terminal site for i = 1, i = 2 and i = 3. See Results 
section for definition of parameters.
53
DISCUSSION
The successful modification of histidine with 
aquopentaammine ruthenium*II) reagent to form stable 
pentaammine ruthenium-histidine complexes on diferric and 
C-terminal monoferric transferrin at neutral pH has been 
carried out. The reaction appears to be specific for 
histidines under the conditions described at reaction 
times up to 60 hours. Extensively modified protein
consists of 6 modified histidine residues for diferric and 
S modified residues for C-terminal monoferric transferrin. 
The larger number of histidines modified in the monoferric 
protein is likely due to exposure of 2 histidines that are 
normally buried within the interior of the N-terminal lobe 
when iron is bound.
The electrostatic influence of the Ru(III) complex is 
probably responsible for the increase in rate of Fe 
release for the N-terminal site. The presence of
octahedral RutNH^J^-His may influence the local structure 
of the protein near the iron, resulting in a
destabilization of the binding site. Another explanation 
is that the binding of mediators by the modified histidine 
is greatly enhanced due to the greater positive charge. 
Since the EPR spectrum shows that the iron binding site is 
essentially unaltered upon modification and titration of 
Fe(NTA)2 into modified protein shows that ruthenium 
incorporation does not inhibit iron binding, the second
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possibility is the favored explanation.
The apparent linearity of a 1/i- v s . X for i=2 and i=3 
show neither value can he excluded in determining the 
number of essential residues for the N-terminal site. More 
kinetic studies are needed to determine the i-value with 
certainty. In either case however, the value is in 
contrast with chemical modification of histidine using 
ethoxyformic anhydride where only one histidine was found 
to be essential. X-ray data for the N-terminal site 
indicate several surface-accessible histidines which makes 
either i = 2 or i=3 a reasonable result. Also, the different 
modification reagents are likely to have had different 
effects on the Fe release kinetics (i.e. charge, sterics). 
The increase in k^ with no increase in upon Ru(III)
modification suggests the involvement of histidine 
residues which are not conserved in both domains. The 
X-ray diagram of lactoferrin shows HIS-26, HIS-276 and 
HIS-292 in the N-terminal lobe are on the protein surface 
and have no counterparts in the C-terminal domain. The 
corresponding residues in the N-terminal serum protein are 
HIS-25, HIS-273, and HIS-289. It is possible these
residues are responsible for the observed kinetic effects. 
The presence of these non-conserved residues in the 
N-terminal site may also explain the observed kinetic 
stability of the C-site relative to the N-site in acidic 
media.
55
Further work is needed to determine the histidines 
which bind Ru(NH3 )5 - Such a study would involve the
location of the modified histidines in the sequence by
tryptic hydrolysis followed by HPLC of the peptide
mixture. This method has been successful with low
molecular weight proteins.6 2 ' High field NMR may also be
used to determine which histidines are modified. The
paramagnetism of the ruthenium(III) would likely have an




ESTIMATION OF THE DISTANCE BETWEEN THE METAL 
BINDING SITE AND HISTIDINE-Ru(III) COMPLEX 
USING ENERGY TRANSFER FLUORESCENCE SPECTROSCOPY
INTRODUCTION
Distances in macromolecules can be measured by
71fluorescence energy transfer spectroscopy. in this study 
the distance from the iron binding site to neighboring 
histidines was determined using Ru(III) modified 
transferrin with terbium bound in the iron sites.
In the energy transfer experiment, the energy from an 
excited donor is transferred via a dipole-dipole, 
non-radiative mechanism to a second chromophore, the 
acceptor. The transfer between the two moieties can occur 
at distances up to 60 A. Forsters' equations relate the
efficiency of energy transfer to the spectral 
characteristics of the donor and acceptor, the relative 
orientation of their transition dipoles, and the distance 
between them.7^'7^
E = 1 - (1/1 0j = 1 - (t /t o ) = Cl + (r/R0)63'1 (Eq. 3.1)
Equation 3.1 shows that the efficiency of energy 
transfer, E, is related to the experimental fluorescence 
intensity, I, or fluorescence lifetime, t, I0 and x 0 being 
the intensity and lifetime of the donor in the absence of 
an acceptor. E is inversely proportional to the sixth 
power of the donor-acceptor distance, r. R 0 is the 
Forster critical distance, the distance at which half of 
the excited donors are quenched by energy transfer to the 
acceptor. R 0 is a characteristic distance for every
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donor-acceptor pair and can be expressed by Equation 3.2.
R o 1/6 (cm) = 8.78 x 10-zs(KZrr*$J) <Eq. 3.2)
2
where k. is the dipole-dipole orientation factor, tj is the 
index of refraction of the intervening medium, * is the 
fluorescence quantum yield of the donor in the absence of 
energy transfer and J is the value of the overlap 
integral. J is a measure of the degree of overlap between 
the absorption spectrum of the acceptor and the 
fluorescence emission spectrum of the donor. The overlap 
integral is given by Equation 3.3.
/FUJetXJX* dx
J = ---------------------- (cm M L) (Eq. 3.3)
/F(X) dx
where F ( x ) is the fluorescence intensity (in arbitrary 
units) of the energy donor at wavelength x (in cm), and 
e (x ) is the molar absorptivity (in M-1cm~^) of the 
acceptor.
The validity of the above equations has been 
demonstrated using well defined model systems. Figure 





Figure 3.1; Representation of energy transfer between a 
bound terbium ion (donor) and a nearby Rut I II)-histidine 
complex (acceptor) for one of the transferrin binding 
sites. Transfer of energy from donor to acceptor results 
in fluorescence quenching of donor emission. The 
efficiency of energy transfer is proportional to the 
inverse sixth power of the distance, r, between the donor 
and acceptor.
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to transferrin is the donor and the Ru(NH3 >5-His complex 
is the acceptor chromophore. The possibility that two or 
more Ru(NH^)^-His molecules close enough to participate in 
energy transfer from the excited terbium cannot be 
excluded. If parallel first order kinetics for energy 
transfer from the donor to several acceptors is assumed, 
the transfer efficiency for N acceptors is given by 
Equation 3.4.
Z <R0/r_. )'
E(N) = (E q . 3.4)
where ri is the distance from the donor to the i
acceptor, the sum is over N pairs, and R 0 is assumed to be
75the same for all donor-acceptor pairs.
Lanthanide(III) ions such as Tb(III) are 
distinguished among metallic cations in their ability to 
fluoresce in solution at room temperature.75 For terbium
complexes in aqueous solution, essentially all emission
c
emanates from the state when the excitation energy is
77less than at 480 nm. The lowest energy multiplets
Q
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Figure 3.2; Fluorescence emission emanates from the D4 
excited state of Tb(III) in diterbium transferrin. Direct 
excitation occurs by absorption of 488 nm light using an 
argon laser. The D. state can also be populated 
indirectly by excitation of the aromatic ring in tyrosine 
to the S. level followed by S, > T, transition. Relaxation 
energy to the bound terbium. Adapted from reference 83.
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The terbium ion can be excited with a 488 nm argon 
ion laser. The input intensity of a laser is required due 
the low molar absorptivity, £,r,D = 0.005 M -1cm-1.
Aternatively, the state can be populated indirectly by
uv excitation of an adjacent aromatic group such as a 
coordinated tyrosine in transferrin, followed by
intramolecular energy transfer to terbium shown in Figure
7 83.2. Since the molar absorptivity is relatively large
*e295 = M "^cm a xenon arc source is suitable for
energy transfer measurements using indirect excitation.
Energy transfer has been used to probe the distance 
between the two metal ions in transferrin by observing 
Tb®+ at one site and Fe®+ or Mn®+ at the other site7 ®  Yeh 
and Meares used fluorescence energy transfer to examine 
the distance of closest approach between metals attached
to transferrin and freely diffusing Tb3+ chelate complexes
78in solution.
Diterbium transferrin has been characterized using uv
difference absorbance and fluorescence spec-
14  79  8 0troscopy. ' ' The potential use of terbium transferrin
as a label for the immunoassay for gentamicin has also 
81been studied.
Recent studies suggest that previous data on terbium 
binding to transferrin may have been misinterpreted.®^ 
Harris has shown that bicarbonate interferes with terbium
binding, apparently due to the formation of lanthanide
82carbonate complexes. Previous energy transfer studies
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using terbium were done with 5 25 mM
14 7 9  80
bicarbonate. ' ' When no bicarbonate was added, an
increase in binding capacity was observed for lanthanide
. , 82 metals.
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MATERIALS AND METHODS
Precautions were taken to avoid trace metal ion
impurities. Clean labware was soaked in 6 M HC1 followed
by rinsing with doubly distilled deionized water. Good
Buffers were chosen for their lack of contamination by 
84heavy metals. Reagent solutions were stored over Chelex 
100. The supernatant was carefully decanted before use. 
Protein solutions were centrifuged just prior to 
experimentation to remove trace particles which might
interfere with fluorescence measurements. Chemicals were 
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Native and Modified Transferrin
Iron-free native transferrin was prepared and assayed 
as described in Chapter I. C-terminal and diferric 
transferrin were modified with aquopentaammine
ruthenium(II) and subsequently made iron-free using
protocols described in Chapter II.
In an attempt to deactivate N-terminal histidine 
ligands, ruthenium-modified C-terminal transferrin was 
further modified with ethoxyformic anhydride (EFA). In 
this procedure, EFA was added in 1 - 5 pL increments to a 
stirring solution of 4.6 - 4.9 pM C-terminal protein in
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0.10 M HEPES, pH 7.3, to make a final concentration of 1.2 
x 10 ^ M in EFA. The extent of modification was monitored 
by uv-difference spectroscopy at 242 nm using
ruthenium-modified C-terminal protein as the reference. 
The solution was then ultrafiltered using an Amicon cell 
fitted with a PM30 membrane. The volume was replaced 
three times (90% V/V per change) with 0.010 M HEPES, pH
7.3, and the protein concentrated and fro 2 en until use.
Fluorescence Studies
Fluorescence work was initially performed using a 
Perkin-Elmer 204 spectrophotometer equipped with a 
Xenon-arc excitation source. The instrument has a rotary 
turret which can accommodate up to four cuvettes per 
experiment. Unless otherwise stated, fluorescence 
measurements were made at room temperature with an 
excitation wavelength of 295 nm.
To determine the effect of aqueous terbium
fluorescence on terbium fluorescence bound to native
-4protein, aliquots of 1.5 x 10 M TbCl3 were added to 3 mL 
of 2 yM native transferrin in 0.050 M HEPES, pH 7.5, to 
100% saturate the protein. The same volume of TbCl^ was 
titrated into a blank solution containing 0.050 M HEPES. 
The emission spectrum was scanned from 460 - 650 nm. It 
was determined that the fluorescence intensity
contribution of aqueous terbium was negligible at the 
sensitivity setting used for terbium transferrin.
66
A pH study was performed to determine the pH range
where two moles terbium bind quantitatively per mole of
native or modified transferrin. A series of 2.0 pM native
or modified proteins were prepared in 0.050 M HEPES, pH S
or pH 9, and 0.050 M CAPS (3-CCyclohexylamino3-l-
propanesulfonic acid), pH 10.0. Terbium chloride (1.5 x 
— ^
10 M) was added in 10 pL aliquots to 3.0 mL of protein 
and the increase in emission intensity was monitored at 
544 nm until equilibration occurred ( 5 - 4 0  min depending 
upon the sample). Native transferrin binds two moles of 
terbium quantitatively at pH 7.0, 8.0 and 10.0. Modified 
transferrin binds quantitatively only at pH 10.0 however. 
Therefore, all subsequent fluorescence studies were made 
at pH 10.0.
A Beer's law plot determined the concentration range 
where fluorescence intensity was linearly proportional to 
the concentration. The linear range was 0.5 pM - 3.0 pM 
and 2.0 pM - 6.0 pM for native and modified transferrin 
respectively.
Terbium Titrations 
Iron-free native and modified transferrin stock 
solutions were diluted to 0.50 - 2.0 pM and 2.0 - 6.0 pM
respectively with 0.010 M HEPES, pH 7.0. The exact 
concentration was determined spectrophotometrically using 
e280nm = x M -^cm 1 . Solid CAPS buffer was added
to the solution to make a final concentration of 0.050 M
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in buffer. The pH was then adjusted to 10.0 using dilute 
n h 3 .
The proteins (3.0 mL) were titrated with 10 - 20 yL 
aliquots of 1.5 x 10 4 M TbCl^ and fluorescence was 
monitored at 544 nm or 487 nm. When aliquots were added 
to fluorescence cuvettes, the solution was carefully mixed 
with a fire-polished pipette. The shutter to the sample 
was closed between titration readings to prevent 
photodegradation. Typical equilibration time was 20 
minutes for modified samples. Native apotransferrin (0.50 
or 1.0 uM) was always titrated in conjunction with three 
modified protein samples in order to determine 
instrumental variations between runs. Each fluorescence 
measurement was taken at different sensitivities (X10S4 - 
X10S9) to obtain maximum signal on the chart.
Overlap Integral
The emission spectrum used to evaluate the overlap 
integral was obtained using IL-SLM 8000 fluorescence 
spectrophotometer with Xe-arc as the excitation source. 
Native transferrin (2.0 yM in 0.050 M CAPS, pH 10) was 
titrated with terbium and a series of emission spectra 
were obtained from 450 nm to 650 nm. The instrumental 
parameters are listed in Table IV.
The absorption spectrum of the Ru(III)- 
His-transferrin complex (3.56 yM in 0.010 M CAPS,
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Table IV
IL-SLM 8000 Instrumental Parameters 
Using Xenon Arc Excitation
excitation x = 295 nm
lower x limit = 450 nm
upper x limit = 650 nm
bandwidth excitation monochrometer = 2.0 nm
bandwidth emission monochrometer = 12.0 nm
wavelength increment = 0.25 nm
Acquisition Time = 10 s
Acquisition Time (detector) = 0.1 s
Channel Number = A
Photomultiplier Voltage (coarse) = l.o kv
Photomultiplier Voltage (fine) = + 45 to !
Sensitivity = 100
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pH 10.0) from 670 - 300 nm was obtained by difference
spectroscopy using native apoprotein at the same
concentration in the reference cell. Variations in
wavelength 3nm) between the CARY 219A absorbance and
IL-SLM8000 fluorescence measurements were corrected with a 
standard solution of rhodamine B (tetraethyl rhodamine;
_7
2.9 x 10 M in ethanol) which has excitation and emission 
peaks at 541 nm and 580 nm respectively.®5 A  computer 
program using trapezoidal quadrature equations in 
increments of 1.0 and 2.0 nm was used to evaluate the 
overlap integral.
The Tsou Chen Lu statistical method was employed to 
determine the number of histidine residues involved in the 
fluorescence quenching of transferrin modified with
pentaammine ruthenium. The extent of Ru modification was
determined by atomic emission as described in Chapter II.
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RESULTS
When terbium is bound to transferrin the fluorescence 
intensity is greatly enhanced. The fluorescence emission
spectra from 450 - 650 nm of terbium in water and in
transferrin (4.0 x 10 Tb) are shown in Figure 3.3. The 
emission intensity of aqueous terbium has been amplified 
5000 times in order to compare its spectral shape with 
terbium transferrin (100% saturated). The three peaks for 
aqueous terbium occur at 481, 537 and 582 nm. The binding 
of terbium to the protein led to bathochromic spectral 
shifts occuring at 487, 544, 583 nm and the appearance of 
a small peak at 620 nm. The most striking contrast
between the two spectra is the appearance of a doublet at 
487 nm. This shows that terbium indeed binds in two 
different environments leading to two resolvable 
transitions. These observations are consistent with 
previous studies.14,78'®0
Native transferrin (20 pM) in 0.10 M HEPES, pH 8.9,
was titrated with Tb8 + . The increase in fluorescence 
intensity was monitored at 487 nm and 544 nm
simultaneously. The titration curves are shown in Figure
3.4 for both wavelengths. Fluorescence intensity rose 
sharply as terbium was initially bound to transferrin, 
continued to increase more gradually after the addition of
1.5 moles of Tb per mole of protein and leveled off at 2.0 
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Figure 3.3; The fluorescence emission intensity of aqueous 
Tb(III)(dashed line), and Tb-transferrin 10Q% saturated 
(solid line). Conditions: 4.0 x 10 M Tb(III) in
unbuffered aqueous solution and in 20 pM transferrin in 
0.050 M HEPES, pH 8.5. The emission intensity of the 
aqueous terbium has been amplified 5000 times in order to 
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Figure 3.4; Titration of native transferrin with Tb(III). 
Conditions: 20 yM apotransferrin in 0.10 M HEPES, pH 8.9.
The emission intensity is shown at 487 nm (A) and 544 nm (B) 
as a function of the amount of terbium. FILE: TB487, TB544, 
Disk# 2
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The maxima at 544 nm was chosen for use in energy transfer 
measurements due to its greater emission intensity. In
subsequent experiments native transferrin was shown to
bind 2 moles of terbium per mole of protein in the pH
range 7 - 10.
The degree of binding as a function of pH for ruthenium 
modified transferrin (5.5 His residues modified) is shown in 
Figure 3.5. When transferrin was titrated at pH 8, the 
fluorescence intensity increased until 1.2 moles of Tb were 
added per mole of transferrin. Further addition of terbium 
led to a decrease in signal. This effect was observed for 
all modified proteins at pH 8 and 9. In all cases, the 
binding of 2 moles of terbium occurred at pH 10.
Fluorescence quenching due to modification with
ruthenium is illustrated by titration curves in Figure 3.6
for native and modified transferrin (3.8 and 6.0 His
residues). The fluorescence intensities of the modified
*
proteins were amplified four-fold in order to be observed on 
the same plot. The modified proteins bound 1.8 - 2.0 moles 
of terbium at pH 10, showing that ruthenium modification did 
not inhibit binding. The degree of quenching, or reduced 
energy transfer efficiency was 80, and 98.3% for 3.8 and 6.0 
modified residues, respectively.
Fluorescence studies of transferrin modified to varying 
degrees with pentaammine ruthenium are shown in Figure 3.7 
in the form of a Tsou Chen-Lu plot. In this study, a is the 
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Ficrure 3.5: Terbium titration into modified protein (5.5 
residues modified). Curve A, 2.0 yM protein in 0.050 M 
CAPS, pH 10. Curve B, 2.0 |iH protein in 0.050 M HEPES, pH
8. Binding of 2 moles of terbium occurs at pH 10 (see 
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Ficrure 3.6: Titration curves for native (A), 3.8 residues 
modified (B) and 6.0 residues modified (C). The emission 
intensity for the modified proteins have been amplified by 
a factor of 4 and that of the native attenuated by a 
factor of 2 in order to display the curves on the same 
plot. The y-axis on the right refers to extensively 
modified transferrin (n). Conditions: 1.9 - 2.1 pM
proteins in 0.050 M CAPS, pH 10.0. The degree of 
quenching is 80% and 98.3% for 3.8 and 6.0 modified 





























0.0 0 . 2 5 0 . 5 0 0 . 7 5 1.00
X
Figure 3.7: Tsou Chen-Lu plot for i = 2 and i = 1 (inset). 
A linear plot for i = 2 suggests that 2 histidines are 
responsible for fluorescence quenching (see Results).
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modified residues in a pool of six equally reactive 
histidines. A linear plot is obtained when i = 2,
implying that two histidines are principally responsible 
for the fluorescence quenching observed.
The Forster critical distance R q is directly
-4 2proportional to J, r| , $, and k . Of these terras only
the overlap integral J can be measured experimentally.
The degree of spectral overlap is shown in Figure 3.8 for
the fluorescence emission of diterbium transferrin and the
ruthenium absorption spectrum as iron-free modified
transferrin (6.0 His residues modified). The spectra have
been corrected for wavelength variations between the two
instruments. The overlap integral from 450 - 650 nm was
evaluated to be 2.81 x 10-15M -1cnf1 using Equation 3.3.
2
The factor k is a measure of the angular dependence 
between the transition dipoles of the donor and acceptor. 
A value for can range from 0 to 4. In this study, the 
isotropic value of 2/3 was used. This assumes that the 
donor and acceptor rotate freely in a time that is short 
compared to the excited state lifetime of the donor, a 
situation normally obtained with Tb(III)-protein 
complexes.
The quantum yield, for Tb-transferrin cannot be
directly measured due to its low molar absorptivity at 488 
nm (e ^ 10"^ M'^cm"*^). Upper and lower limits of 0.25 and 
0.68 have been estimated by O'Hara and coworkers using 
lifetime measurements. Recommended values for the index
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Ficrure 3.8: Degree of spectral overlap for the
Tb-transferrin emission spectrum (A) and the pentaammine 
ruthenium-histidine absorption spectrum (B) . The overlap 
integral was evaluated to be 2.81 x 10 M cm by 
Equation 3.3.
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of refraction, tj, for protein solutions are 1.33 - 1.50.86
The maximum degree of quenching for the extensively
modified protein (6.3 His residues) occured where I/I =o
0.017. Using the upper and lower limits for rj and 4^, the 
distance was calculated to he between 1.14 nm and 1.25 nm 
with corresponding Rq values between 2.25 nm and 2.46 nm. 
The results from the Tsou Chen-Lu plot indicate that two 
histidines are contributing to energy transfer. The 
distance, using Equation 3.4 with N = 2, thus becomes 1.32 
nm to 1.42 nm. This calculation assumes that energy 
transfer follows parallel first order kinetics with R q 
being the same for both donor acceptor pairs.
An attempt to totally deactivate the N-terminal site 
prior to fluorescence energy transfer measurements by 
ethoxyformylating C-terminal transferrin which had been 
previously modified with pentaammine ruthenium was not 
successful. A comparison of the histidine residues Ru 
modified before and after ethoxyformylation showed that 
EFA displaced some ruthenium histidine residues. Upon 
modification with EFA, partially modified C-terminal 
transferrin, (7.0 residues) the amount of ruthenium 
contained on the protein decreased to 2.8 residues 
modified. For 8.1 Ru(III) residues modified the amount 
decreased to 3.45 when the protein was treated with EFA. 
In addition, fluorescence titration studies on doubly 
modified transferrins indicated binding of ^2 moles Tb.
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DISCUSSION
Preliminary fluorescence experiments reveal 
interesting features of the binding of terbium to 
transferrin. In particular, the binding chemistry appears 
to change when ruthenium is incorporated into the protein. 
The titration curve for terbium binding to native 
transferrin in the pH range 7.0 - S.5 shows two breaks at
^1.2 and 2.0 moles of added terbium, indicating the 
stepwise binding of the metal to the protein (Figure 3.4). 
In contrast, ruthenium(III) modification inhibits the 
binding of two moles of Tb(III) at pH values less than 10. 
For example, Figure 3.5 shows the initial binding of 
terbium to one site at pH S. As the titration progresses, 
however, the fluorescence intensity decreases. The 
incorporation of Rut III) may render the binding region too 
positively charged for complete Tb(III) binding at pH 
values lower than 10. When the same titration is carried 
out at pH 10, the ruthenium modified protein binds two 
moles of terbium, implicating the deprotonation of 
tyrosines and/or lysines residues (pK 'VilO) in the binding 
of the metal.
EPR and optical measurements at pH 10 indicate that 
dithorium and divanadyl transferrins undergo a 11C- to N- 
conformational change" making the C-terminal binding site
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spectroscopically identical to the N-terminal site. 
Additional experiments are needed to determine the type of 
conformational transition occuring at pH 10. The titration 
data of modified transferrins suggests equivalent binding 
affinities in the two sites for Tb(III) at pH 10 since two 
separate breaks are not observed (Figure 3.6). This 
observation is consistant with a conformational transition 
at pH 10.
The results from energy transfer studies of proteins 
extensively modified with ruthenium(III) indicate the 
donor-acceptor distance is between 1.14 nm and 1.25 nm 
using the upper and lower values for n and $ (see 
Results). If two histidines are responsible for energy 
transfer as implicated by the Tsou-Chen Lu method, the 
range becomes 1.32 nm to 1.44 nm. The actual distance is 
probably smaller than calculated here since the protein is 
incompletely modified.
For exact calculations, the Rq for each acceptor 
should be considered separately, by measuring the degree 
of fluorescence quenching and evaluating the overlap 
integral for each donor acceptor pair. Gennis and Cantor 
have performed exact energy transfer calculations for one 
donor and multiple acceptors, treating each R q 
independently.^ The results differed by 15% from the 
assumed value showing that Equation 3.4 is acceptable for 
semi-quantitative measurements.
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The amino acid sequence data for human serum 
transferrin shows there are four histidines conserved in 
both domains. By viewing the stereodiagram of the 
a-carbons of the lactoferrin structure, the distance 
between these hisidines and the metal site can be 
estimated. The following designations are numbered 
according to sequence of serum transferrin The distance 
between oi-carbons in an a-helix is taken as 0.15 nm. 
Histidines-119, HIS-207, and HIS-242 in the N-terminal
domain and their counterparts in the C-domain, are within 
the calculated upper limit of 14.4A. Histidine-119 and 
HIS-242 are approximately the same distance to the metal. 
From the stereodiagram HIS-119 is seen to be partially 
buried by helical strands, making it the least likely to 
form the pentaammine ruthenium-HIS complex. Histidine-242 
is a surface accessible residue. Histidine-207 is the 
closest to the metal site and is positioned between 
TYR-188 and TYR-95 protein ligands. Like HIS-242, HIS-207 
is also surface accessible.
In conclusion, histidine residues not coordinated to 
the metal are very likely involved in the iron release 
reaction. Histidines 207 and 545 are strong candidates. 
However these assignments were based on the lactoferrin 
structure and slight differences in amino acid sequencing 
could lead to different positioning of histidines in human 
serum transferrin. These assignments are based on an 
X-ray structure and may not reflect the dynamics present 
in solution.
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Possible future work should include separation of 
partially modified proteins via cation exchange 
chromatography. This would permit isolation of the two 
histidines so that an exact R q can be determined for each 
residue. The determination of the quantum yield would 
reduce the uncertainty values in the distance (An error of
0.2 in | leads to an error of 8.3% in R 0). An indirect 
method for measuring the quantum yield of terbium 




The differences in rates of iron release using EFA 
and pentaammineruthenium(II) chemical modification 
reagents point toward a possible dual role for 
non-coordinated histidines in transferrin. Previous 
studies in this laboratory have implicated a single 
histidine near the metal in each domain is involved in the 
iron release mechanism. In contrast, this study suggests 
two non-conserved histidines in the N-terminal site are 
involved. Pentaamraineruthenium(II) is known to react 
appreciably with only surface accessible residues whereas 
EFA is probably small enough to diffuse into the interior 
near the binding site. The X-ray structure shows that 
many of the surface accessible histidines are contained in 
the outer coils of ot-helixes (Figure 3.9). One possible 
function of these histidines is to stabilize the 
conformational folding of the protein by hydrogen bonding 
to other amino acids. When histidine is not protonated, 
both nitrogens can act as either a donor or acceptor of 
hydrogen bonding. Upon ionization however, histidine 
loses this amphiprotic property possibly destabilizing 
other amino acids and triggering a conformational change. 
Examination of the structure also shows non-conserved 
histidines present only in the N-terminal lobe may explain 
some of the differences between the acid lability of the
85
N-terminal site as well as the marked increase in rate of 
iron release from the N-site upon modification with the 
ruthenium(III) reagent.
86
Figure 3.9: Stereodiagram of the a-carbons in the X-ray
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